|
Cryptococcal
Meningitis in a Patient with Hepatitis C Cirrhosis
Presenting with Acute Demyelinating Polyneuropathy
of the Guillian-Barré Type
Al
Ani M.A., Mubarak A.A., Al Azawi A. and Al Qahtani
A.
Department of
Medicine, Hamad Medical Corporation, Doha, Qatar
Abstract:
Cryptococcal meningitis is a
rare disease that can affect both immunocompetent
and immunocompromised patients. A patient
presenting with proximal muscle weakness was found
to have cryptococcal meningitis. Nerve conduction
studies (NCV) confirmed the proximal weakness as
acute demyelinating polyradiculoneuropathy. During
treatment the patient developed drug-related acute
renal failure. He was then treated successfully
with an alternative drug. A discussion of
cryptococcal. meningitis and its treatment is
presented.
Key words: Cryptococcal
Meningitis, Liver cirrhosis
 Introduction:
Cryptococcal meningitis is
caused by Cryptococcus neoformans, a ubiquitous
encapsulated yeast of which two varieties are
significant in man, C. neoformans var. neoformans
and C. neoformans var. gatti[1]
. The organism has been found in dried pigeon
droppings, contaminated soil and leaf and bark
samples from various gum trees growing in tropical
and subtropical regions. The organism can also be
detected in air samples when the trees are
flowering[1] (Ellis
and Pfeiffer 1990). Meningitis is the most common
presentation of cryptococcosis. Patients with
liver cirrhosis are at increased risk of fungal
infection because of decreased opsonin function,
impaired complement and leukocyte dysfunction[2].
In this report we present a case of progressive
proximal weakness due to acute demylinating
polyneuropathy in a patient with hepatitis C
cirrhosis and cryptococcal meningitis.
  Case
Report :
A fifty-four year
old Egyptian male presented with one-week history
of progressive weakness of the lower limbs. He was
unable to climb the
stairs or to stand up from sitting position. There
was no history of fever, headache, nausea,
vomiting or change in bowel habits. He was a known
case of hepatitis C cirrhosis complicated by
gastric and oesophageal varices for the last three
years.
He was a middle-aged man of average build who
was fully alert and orientated, with a palpably
enlarged spleen 4 cm below the costal margin.
Examination of the nervous system showed normal
power, tone and reflexes in the upper limbs. In
the lower limbs, power was 3/5 with absent ankle
and knee jerks; plantar reflexes were decreased.
Sensation was intact and there were no signs of
meningeal irritation.
  Laboratory Investigations:
Blood count
revealed a white cell count of 3.09 cells/mm3,
Hb 9.25 g/dl, platelets 39.8 /mm3,
International normalised ratio 1.4. CD3 and CD4,
alpha-fetoprotein, thyroid function tests, urea
and electrolytes, liver function tests, CT of
brain were all normal, and he was HIV negative. An
MRI of the thoraco-lumbar spine did not show any
evidence of cord compression. Nerve conduction
studies showed a slight delay in motor latency of
the left median nerve, slight reduction of
conduction of the left peronius profundus nerve,
delayed f-wave latency of the left peronius
profundus with conduction block; findings
consistent with early demyelinating neuropathy.
Sensory conduction was normal. Lumbar puncture
examination was suggestive of meningitis, WBC
2200/mm3.
lymphocytes 15%, polymorphs 85%. Grams stain,
Bacterial latex test, and stain for AFB’s were
all negative. Culture produced a growth of
Cryptococcus neoformans. The patient was started
on amphotericin B but developed renal failure
after the second dose and treatment was changed to
fluconazole 400 mg orally once daily. After four
weeks, the lumbar puncture was repeated. A cell
count was not done because of contamination with
extraneous blood. After centrifugation, cytology
showed numerous lymphocytes. Culture produced no
fungal growth. Treatment continued for ten weeks
with remarkable increasing strength of the patient
who is now doing well 18 months after discharge
from the hospital.
  Discussion:
Cryptococcosis is a
life-threatening systemic fungal infection caused by
monomorphic yeast Cryptococcus neoformans[3].
Despite the high prevalence of the organism in the
environment, human cryptococcal infection is rare
except in patients with disorders of cell-mediated
immunity such as AIDS, immuno-suppression and lympho-reticular
malignancies.
Our patient was known to have
hepatitis C cirrhosis and portal hypertension and he
presented with progressive proximal lower limb
weakness with areflexia and neurophysiological
findings consistent with the diagnosis of
Guillian-Barré syndrome, a presentation reported
before[4].
Patients with liver cirrhosis due to elevated levels
of chemotactic inhibitors and reduced complement
level are at higher risk of bacterial and fungal
infections. [5].
One study found liver cirrhosis to be the underlying
cause of cryptococcal illness in 6.3%. (third
commonest cause)[2].
Rare case reports of cryptococcal peritonitis
[2] ,
arthritis and
myositis[6]
have been described in patients with hepatic
dysfunction.
Meningitis is the most common
presentation of cryptococcal infection, and CNS
disease may be accompanied by infection in
extra-cranial sites, particularly the lungs which
may be the primary site of infection[1,7].
In one of the most comprehensive studies of the
clinical features of cryptococcosis, the CNS was
involved in 76% of 171 patients with similar rates
for immunocompetent and immunosuppressed with or
without AIDS[8].
A myriad of neurological symptoms has been
reported. Headache and fever being the most common
followed by neck stiffness (75%), nausea and
vomiting (50%)[
9]. The signs of
meningeal irritation may take weeks to develop [10].
The early diagnosis and treatment in our patient
might explain the absence of these signs.
Diagnosis is established by
demonstrating Cryptococcus neoformans during the
active disease state. This may be done by direct
microscopic examination of CSF using an Indian ink
preparation, by isolation in culture or by detection
of cryptococcal antigen. Culture yields the organism
in 87 to 100%[10].
CSF culture was positive in our patient and
treatment with amphotericin B was initiated but the
renal function deteriorated after the second dose
and treatment was changed to fluconazole. The CSF
was sterile after four weeks of treatment but
fluconazole was continued for ten weeks.
Recent studies that have
identified optimal treatment strategies for
cryptococcal infections have been of patients with
AIDS. These studies suggest initial treatment with
amphotericin B with or without flucytocine which
allows more rapid sterilization of CSF than
fluconazole[6],
Fluconaxole 400 mg daily for ten weeks has been used
as an alternative to amphotericin B in treating
cryptococcal meningitis in AIDS[11]
In a study of meningeal and
extra-meningeal cryptococcosis in HIV-negative
patients treated with amphotericin B (43 patients)
or fluconazole (40 patients), a cure rate of 77% was
achieved in both groups of patients and fluconazole
appears as effective as amphotericine B[12].
In conclusion we have described a patient with
cryptococcal meningitis and hepatitis C cirrhosis
who was admitted as a case of bilateral
predominantly proximal weakness of the legs. Nerve
conduction studies confirmed the presence of
demylinating neuropathy that was successfully
treated with fluconazole with uneventful recovery.
  Acknowledgements:
We would like to thank Dr. Tag Eldeen Sokrab,
Dr. Hussam Al Soub, Dr. Soufyan Abbas, Dr. Muataz
Al-Izzi, for their comments, and Mrs. Elizabeth
Eweka for typing the manuscript.
 References:
1.
Jones GA; Nathwani D. Br J Hosp Med 1995 Nov 1-14;
54 (9): 439-45.
2.
Mabee CL; Mabee SW; Kirkpatrick RB et al. Cirrhosis:
A risk factor for cryptococcal peritonitis. AM J
Gastroentero- logy 1995; 90: 2042-5.
3.
White MH; Armstrong D. Cryptococcosis. Infect Dis
Clin North AM. 1994 Jun; 8(2): 383-98.
4.
Dichgans M; Seelos K; Wick M; Pfister HW.
Meningoradiculity with severe tetraparosis and
unusual manifestation of infection due to
cryptococcus neoformans variety gatti. Clin Infect
Dis. 1998 Feb; 26(2): 524-5.
5.
AN, Anderson BR. Defective chemotaxis associated
with Demo serum inhibitors in cirrhotic patients N
Engl j Med 1972; 286: 735-40.
6.
SD Flagg, YJ Chang, CP Masuell et al. Myosititis
resulting from disseminated cryptococcosis in a
patient with hepatitis C cirrhosis. Clin-Infect-Dis.
2001; 32; 1104-7.
7.
LallooD; Fisher D; Naraqi S; Laurenson I; Temu P;
Sinha A; Saweri A; Mavo B. Cryptococcal meningitis.
Q J Med 1994 Jun; 87(6): 343-9.
8.
Rozanbaum K, Goncalves SAJR. Clinical
epidemiological study of 171 cases of cryptococcosis.
Clin-infect-Dis. 1994; 18: 369-80.
9.
Walter T. Hughs. Principle and Practice of infection
disease 4th Edi. pp 2332-36.
10.
Saadah MA; Araj GF; Diab SM; Nazzel M. Cryptococcal
meningitis and confusional psychosis. A case report
and literature review. Top Geogr Med. 1995; 47(5):
224-6.
11.
White M H Armstrong D. Cryptococcosis. Infect. Dis.
Clin North Am. 1994; 8: 388-99.
12.
Francoise Dromer; Simone Mathoulin; Bertrand Dupont;
et al. Comparison of the efficacy of Amphotericin B
and Fluconazole in the treatment of cryptococcosis
in human immunedeficiency virus-negative patient.
Retrospective analysis of 83 cases. Clin Infect Dis.
1996; 22 (suppl 2) S 154-60.
|